Drug Development

A two-day event at the Stanford School of Medicine brought together investors, regulators, company executives and scientists to discuss the most productive ways for them to work together.

A genetic variant that inhibits alcohol metabolism harms blood vessel cells, but an antidiabetic medication may mitigate the harm, Stanford Medicine-led research has found.

In a trial led by Stanford Medicine researchers, more than half of patients with persistent smell loss saw improvement with injections of platelet-rich plasma.

The collaboration will enable the development of medications to treat a type of brain cancer.

A discovery by Stanford Medicine researchers and colleagues may pave the way for a “morning after” or prophylactic nasal spray to prevent infection.

In a new clinical trial, Stanford Medicine researchers found that a commonly used anti-nausea drug could reduce the severity of opioid withdrawal in newborns.

Stanford Medicine researchers have created a molecule that blocks an enzyme thought to be instrumental in causing colon cancer relapse or chemotherapy resistance.